Business Today
Subscribe
PMS TodayBudget 2025US NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Prism Medico & Pharmacy Ltd
Prism Medico & Pharmacy Ltd

Prism Medico & Pharmacy Ltd Share Price

  • Sector: Trading (Small Cap)
  • Volume: 2,829
Dec 05, 2025
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹17.49
₹0.08 (0.46%)
16.75Low
Today’s Performance
17.64High
11.62Low
52 Week’s Performance
26.50High

bt_logoStock Performance

  • 1 Day0.46%
  • 1 Week-2.56%
  • 1 Month-11.84%
  • 3 Months0.63%
  • 6 Months10.21%
  • 1 Year-32.26%
  • 3 Years8.19%
  • 5 Years-8.82%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta-0.35
  • 52-Week Low (₹)11.62
  • 52-Week High (₹)26.50
  • Price-to-Book (X)*0.70
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*17.49
  • Earnings Per Share (₹)1.00
  • Market Cap (₹ Cr.)*10.60
* Values as of last close price

bt_logoCOMPETITORS

BT TV

"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive5:31"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive
Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations7:17Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations
FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support5:04FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support
India–Russia Trade to Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership2:31India–Russia Trade To Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership
Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push11:22Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push
IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide3:48IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide
India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities2:42India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities
Passengers Angry Over IndiGo Delays, Complain Of No Information3:16Passengers Angry Over IndiGo Delays, Complain Of No Information
Vikram Misri: India–Russia to Accelerate FTA, Investment Treaty and Key Connectivity Negotiations1:58Vikram Misri: India–Russia To Accelerate FTA, Investment Treaty And Key Connectivity Negotiations
‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War3:01‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War
View more

bt_logoFAQ's

What was Prism Medico & Pharmacy Ltd share price previously?
Prism Medico & Pharmacy Ltd share price was up by 0.46% from the previous closing price of ₹17.41.
Who are peers of Prism Medico & Pharmacy Ltd?
The peers of Prism Medico & Pharmacy Ltd are Adani Enterprises Ltd, Premier Energies Ltd, Aegis Logistics Ltd, Redington Ltd, Cello World Ltd, Honasa Consumer Ltd, MMTC Ltd.
Who is/are the promoter/promoters of Prism Medico & Pharmacy Ltd?
The promotor/promotors of Prism Medico & Pharmacy Ltd are Sakshi Laller, Davender Singh, DINESH KUMAR, Pradeep Kumar, Sameer Gupta.
What has been 52-week high of Prism Medico & Pharmacy Ltd stocks?
The highest price of Prism Medico & Pharmacy Ltd stock is ₹26.50 in the last 52-week.
What is the share price of Prism Medico & Pharmacy Ltd (PRISMMEDI) today on BSE?
As on Dec 05, 2025 Prism Medico & Pharmacy Ltd (PRISMMEDI)’s share price on BSE is Rs 17.49
What is the market cap of Prism Medico & Pharmacy Ltd (PRISMMEDI)?
The current market capitalisation of Prism Medico & Pharmacy Ltd (PRISMMEDI) is 10.60 crores
What is Prism Medico & Pharmacy Ltd Share symbol?
The symbol of Prism Medico & Pharmacy Ltd is .
What is the PE ratio of Prism Medico & Pharmacy Ltd (PRISMMEDI)?
The current PE ratio of Prism Medico & Pharmacy Ltd (PRISMMEDI) is 17.49.
What is the PB ratio of Prism Medico & Pharmacy Ltd (PRISMMEDI)?
The current PB ratio of Prism Medico & Pharmacy Ltd (PRISMMEDI) is 0.70.
Today’s High & Low share prices of Prism Medico & Pharmacy Ltd (PRISMMEDI) on BSE?
Today, the share price of Prism Medico & Pharmacy Ltd (PRISMMEDI) on BSE touched a high of Rs 17.64 and a low of Rs 16.75
What price did Prism Medico & Pharmacy Ltd (PRISMMEDI) shares open on the BSE today?
On BSE, the share price of Prism Medico & Pharmacy Ltd (PRISMMEDI) opened at Rs 17.64
What is the 52-week high of Prism Medico & Pharmacy Ltd (PRISMMEDI)?
The 52-week high price of Prism Medico & Pharmacy Ltd (PRISMMEDI) is Rs 26.50
What is the 52-week low of Prism Medico & Pharmacy Ltd (PRISMMEDI)?
The 52-week low price of Prism Medico & Pharmacy Ltd (PRISMMEDI) is Rs 11.62

bt_logoAbout Prism Medico

Prism Medico & Pharmacy Ltd, incorporated in the year 2002, has its registered office in D-118 Industrial Area, Phase VII, Mohali, Punjab, 160055, 0172-5020762. The main industry in which Prism Medico & Pharmacy Ltd operates is Trading.

Auditor/Auditors for Prism Medico & Pharmacy Ltd is/are Harjeet Parvesh & Co. In the main management, is chairman and Sameer Gupta is the company secretary for Prism Medico & Pharmacy Ltd.

  • SL
    Sakshi LallerWhole-time Director
  • DS
    Davender SinghDirector
  • DK
    DINESH KUMARIndependent Non Exe. Director
  • PK
    Pradeep KumarIndependent Non Exe. Director
  • SG
    Sameer GuptaCompany Sec. & Compli. Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.